Philip Wagenheim - 24 May 2021 Form 4 Insider Report for Immunome Inc. (IMNM)

Role
Director
Signature
/s/ Purnanand D. Sarma, Attorney-in-Fact
Issuer symbol
IMNM
Transactions as of
24 May 2021
Net transactions value
+$247,725
Form type
4
Filing time
26 May 2021, 21:29:41 UTC
Next filing
01 Jun 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IMNM Common Stock Purchase $247,725 +13,500 +3.5% $18.35 397,397 24 May 2021 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $18.15 to $18.40, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price.
F2 Does not include (i) 166,666 shares previously reported as indirectly held by the reporting person because the reporting person is no longer trustee of the Rapoport Family Trust and (ii) 443,743 shares previously reported as held indirectly through BCM Advisory Partners LLC (the "LLC") in which the reporting person did not have a pecuniary interest and which were distributed to other members of the LLC.